Michelet, Robin http://orcid.org/0000-0002-5485-607X
Dossche, Lien
Van Herzeele, Charlotte
De Bruyne, Pauline
Gasthuys, Elke
Van Bocxlaer, Jan
Vande Walle, Johan
Vermeulen, An
Funding for this research was provided by:
Agentschap voor Innovatie door Wetenschap en Technologie (130033)
Article History
First Online: 25 July 2019
Compliance with Ethical Standards
:
: This study was supported by the Agency for Innovation by Science and Technology in Flanders (IWT) through the SAFE-PEDRUG project (IWT/SBO 130033).
: An Vermeulen is an employee of Johnson & Johnson and holds stock/stock options in the company. Pauline De Bruyn, Lien Dossche and Charlotte Van Herzeele received travel reimbursement from Ferring Pharmaceuticals for a presentation at the Ghent-Aarhus Springschool. Johan Vande Walle has received consulting fees and travel reimbursements from Ferring Pharmaceuticals, as well as payment for lectures from Ferring Pharmaceuticals and Astellas Pharma. Robin Michelet, Elke Gasthuys and Jan Van Bocxlaer have no potential conflicts of interest that might be relevant to this article.